Key Takeaways
- • Private equity firms acquired 574 autism therapy centers across 42 U.S. states over the past decade, with nearly 80% of purchases concentrated between 2018 and 2022, according to a January 5, 2026 study published in JAMA Pediatrics.
- • Autism spectrum disorder diagnoses nearly tripled in the U.S. from 2011 to 2022 (2.3 to 6.3 cases per 1,000 children), creating a rapidly expanding market that has attracted PE investment at unprecedented rates.
- • Between 2015 and 2022, private equity firms completed 85% of all mergers and acquisitions in autism services—a consolidation rate higher than any other healthcare segment—with the highest PE clinic ownership in states with the highest autism prevalence rates (24% higher likelihood).
- • Industry experts warn that PE ownership introduces structural pressure for rapid growth and margin expansion, potentially shifting autism therapy centers from service-first models toward revenue-maximization strategies that may compromise care quality.
- • Applied behavior analysis (ABA) therapy—the primary service offered at these centers—uses positive reinforcement to develop patient communication, socialization, self-care, and motor skills, representing a specialized healthcare service segment now dominated by institutional capital.
Summary
Private equity firms have rapidly consolidated the U.S. autism therapy center market, acquiring over 500 clinics in the past decade in what researchers describe as an emerging and distinctly profitable healthcare segment for institutional investors. A study published January 5, 2026 in JAMA Pediatrics identified 574 autism therapy centers owned by PE firms across 42 states as of 2024, with the acceleration in deal flow notable: nearly 80% of these acquisitions occurred between 2018 and 2022.
The timing of PE entry into autism services aligns directly with epidemiological trends. The prevalence of autism spectrum disorder in the U.S. nearly tripled from 2011 to 2022, rising from 2.3 cases per 1,000 children to 6.3 cases per 1,000—with the largest diagnostic increases among children aged 5 to 8. This expanding patient base and corresponding demand for applied behavior analysis (ABA) therapy services created financial visibility that attracted PE capital. Geographic analysis reveals strategic concentration: states with the highest rates of childhood autism diagnoses were 24% more likely to have PE-owned clinics, indicating PE deployment follows epidemiological opportunity.
The consolidation intensity in autism services is unprecedented relative to other healthcare sectors. Between 2015 and 2022, private equity firms completed 85% of all mergers and acquisitions in the autism therapy market—a concentration rate not observed in any other healthcare segment. Yashaswini Singh, health economist at Brown University and senior researcher on the JAMA Pediatrics study, noted that "there is yet another segment of health care that has emerged as potentially profitable to private equity investors, and it is very distinct from where we have traditionally known investors to go."
Stakeholders express concern about operational implications. Arianna Esposito, vice president of services and supports at Autism Speaks, highlighted the core tension: "Private equity ownership can introduce pressure for rapid growth and margin expansion, which may shift organizations away from a service-first model toward one that prioritizes volume and revenue." This dynamic mirrors broader healthcare PE concerns regarding care prioritization versus financial optimization in sectors serving vulnerable populations dependent on therapy services for developmental outcomes.
The timing of PE entry into autism services aligns directly with epidemiological trends. The prevalence of autism spectrum disorder in the U.S. nearly tripled from 2011 to 2022, rising from 2.3 cases per 1,000 children to 6.3 cases per 1,000—with the largest diagnostic increases among children aged 5 to 8. This expanding patient base and corresponding demand for applied behavior analysis (ABA) therapy services created financial visibility that attracted PE capital. Geographic analysis reveals strategic concentration: states with the highest rates of childhood autism diagnoses were 24% more likely to have PE-owned clinics, indicating PE deployment follows epidemiological opportunity.
The consolidation intensity in autism services is unprecedented relative to other healthcare sectors. Between 2015 and 2022, private equity firms completed 85% of all mergers and acquisitions in the autism therapy market—a concentration rate not observed in any other healthcare segment. Yashaswini Singh, health economist at Brown University and senior researcher on the JAMA Pediatrics study, noted that "there is yet another segment of health care that has emerged as potentially profitable to private equity investors, and it is very distinct from where we have traditionally known investors to go."
Stakeholders express concern about operational implications. Arianna Esposito, vice president of services and supports at Autism Speaks, highlighted the core tension: "Private equity ownership can introduce pressure for rapid growth and margin expansion, which may shift organizations away from a service-first model toward one that prioritizes volume and revenue." This dynamic mirrors broader healthcare PE concerns regarding care prioritization versus financial optimization in sectors serving vulnerable populations dependent on therapy services for developmental outcomes.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.